4.5 Article

Human gingival fibroblasts: Isolation, characterization, and evaluation of CD146 expression

Journal

SAUDI JOURNAL OF BIOLOGICAL SCIENCES
Volume 28, Issue 4, Pages 2518-2526

Publisher

ELSEVIER
DOI: 10.1016/j.sjbs.2021.01.053

Keywords

Gingival fibroblasts; CD146; Mesenchymal stem cells

Categories

Funding

  1. University Hospital Foundation Medical Research Competition (UHFMRC) grant

Ask authors/readers for more resources

This study investigated the differentiation potential of GMSCs based on CD146 expression, indicating that solely relying on CD146 for identifying gingival stem cells may not be adequate for translational research on novel therapeutic methods for treating oral disease.
Gingival fibroblasts (GFs) that exhibit adult stem cell-like characteristics are known as gingival mesenchymal stem cells (GMSCs). Specific mesenchymal stem cell (MSC) markers have not been identified to distinguish GMSCs from GFs. Recently, the cell surface molecule known as cluster of differentiation (CD) 146 has been identified as a potential MSC surface marker. In the present study, we investigated the differentiation potential of GMSCs based on CD146 expression. GFs were isolated by two techniques: tissue explants or enzymatic digestion. GFs were cultured and expanded then magnetically sorted according to CD146 expression. CD146(low) and CD146(high) cells were collected, expanded, and then tested for stem cell markers by flow cytometry as well as osteogenic and chondrogenic differentiation potential. The differentiation of these cells was analyzed after 21 days using histology, immunofluorescence, real-time quantitative PCR (qPCR), and glycosaminoglycan (GAG) to DNA ratio (GAG/DNA) assays. Positive histological staining indicated osteogenic differentiation of all groups regardless of the isolation techniques utilized. However, none of the groups demonstrated chondrogenic differentiation, confirmed by the lack of collagen type II in the extracellular matrix (ECM) of GF aggregates. Our data suggest that identification of gingival stem cells based solely on CD146 is not sufficient to properly carry out translational research using gingival fibroblasts for novel therapeutic methods of treating oral disease. (C) 2021 The Author(s). Published by Elsevier B.V.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available